Neurelis Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Neurelis Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011852
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neurelis Inc. (Neurelis) is a specialty pharmaceutical company, which develops medicines to target unmet medical need in epilepsy and acute anxiety episodes. The company’s product portfolio includes NRL-1 (intranasal diazepam), a proprietary formulation, for epilepsy in pediatric and adult patients who need to use diazepam sporadically to control bouts of acute repetitive seizures; NRL-2 (intranasal lorazepam), which gets absorbed rapidly through a nasal spray, providing swift clinical response. Neurelis obtained Orphan drug designation for NRL-1 from the FDA for the treatment of acute repetitive seizures. The company also licenses, develops, and commercializes product candidates for the broader central nervous system (CNS) market. Neurelis is headquartered in San Diego, California.

Neurelis Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neurelis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Neurelis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Neurelis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Neurelis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Neurelis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Neurelis Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Neurelis Raises Funds through Series B Venture Financing 10
Neurelis Raises Funds in Series A Financing Round 11
Neurelis Secures US$1.08 Million In Venture Financing 12
Neurelis Inc – Key Competitors 13
Neurelis Inc – Key Employees 14
Neurelis Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product Approvals 16
Jan 04, 2017: Neurelis Intranasal Diazepam Treatment For Epilepsy Granted Fast Track Designation By FDA 16
Jan 19, 2016: Neurelis Initiates Pivotal Clinical Program for NRL-1 in the Treatment of Acute Repetitive Seizures 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Neurelis Inc, Pharmaceuticals & Healthcare, Key Facts 2
Neurelis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Neurelis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Neurelis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Neurelis Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Neurelis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Neurelis Raises Funds through Series B Venture Financing 10
Neurelis Raises Funds in Series A Financing Round 11
Neurelis Secures US$1.08 Million In Venture Financing 12
Neurelis Inc, Key Competitors 13
Neurelis Inc, Key Employees 14

★海外企業調査レポート[Neurelis Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Datawatch Corporation (DWCH):企業概要、財務及び戦略的SWOT分析
    Summary Datawatch Corporation (Datawatch) is a software development company. The company offers products such as datawatch desktop, datawatch server and datawatch report mining server. Its datawatch desktop include visual data discovery, data visualizations, analysis of real-time streams, time serie …
  • NuStar Energy L.P.:企業の戦略・SWOT・財務分析
    SummaryNuStar Energy L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • China Billion Resources Limited:企業の戦略・SWOT・財務分析
    SummaryChina Billion Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the comp …
  • FuelCell Energy, Inc. (FCEL)(エネルギー分野):企業M&A動向
    Summary FuelCell Energy, Inc. (FuelCell Energy) is an integrated fuel cell company. It designs, manufactures, installs, operates, sells and services ultra-clean stationary fuel cell power plants. The company’s core product is carbonate fuel cell power plant, which is distributed and marketed under t …
  • Findel plc:企業の戦略・SWOT・財務分析
    SummaryFindel plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - D …
  • Rathbone Brothers Plc:企業の戦略・SWOT・財務分析
    SummaryRathbone Brothers Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Champion Technology Holdings Limited (92):企業財務及び戦略的SWOT分析
    Summary Champion Technology Holdings Limited (Champion Technology) is a technology consulting company that provides communication software solutions. The company offers services such as sales of general systems and products, software customization, e-lottery services, software licensing, leasing of …
  • Clifton Mining Company Inc.:企業の戦略・SWOT・財務分析
    SummaryClifton Mining Company Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Simulations Plus, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Simulations Plus, Inc. Mergers …
  • 3-D Matrix, Inc.:企業の戦略的SWOT分析
    3-D Matrix, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • ActiveCare Inc (ACAR):企業のM&A・提携動向(医療分野)
    Summary ActiveCare Inc (ActiveCare) is a diabetes monitoring products and wellness services for self-insured employers. The company provides monitoring component to traditional disease management and wellness solutions. Its solutions include diabetes supplies, online web-based administrative tools, …
  • Balda AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Balda AG Mergers and Acquisitio …
  • Titan Logix Corp. (TLA):企業の財務及び戦略的SWOT分析
    Summary Titan Logix Corp. (Titan) is an oil and gas solution provider that offers instrumentation, control and automation solutions. The company’s products include mobile tank gauging, stationary tank gauging and discontinued products. Its discontinued products offer information for discontinued pro …
  • RPG Industries SE:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' RPG Industries SE Mergers and A …
  • Eguana Technologies Inc. (EGT):企業財務及び戦略的SWOT分析
    Eguana Technologies Inc. (EGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • MicroTransponder Inc.:企業のM&A・提携動向(医療機器分野)
    Summary MicroTransponder Inc. (MicroTransponder) is a medical device company that develops paired vagus nerve stimulation system (VNS) to treat several neurological diseases. The company's paired VNS System is used in two clinical trials for treating tinnitus and upper limb mobility issues for strok …
  • FTS International Services, LLC:企業の戦略的SWOT分析
    FTS International Services, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • KBI Biopharma Inc.(製薬・医療分野):企業M&A動向
    Summary KBI Biopharma, Inc. (KBI) is a biopharmaceutical contract development and manufacturing company. It holds expertise in advanced protein characterization. The company offers products such as antibodies, complex recombinant proteins, recombinant vaccines, novel constructs, peptides and oligonu …
  • Oculus Innovative Sciences, Inc. (OCLS)(製薬・医療分野):企業M&A動向
    Summary Oculus Innovative Sciences, Inc. (Oculus) is a healthcare company. The company develops, manufactures, and markets prescription and non-prescription products. Its products include advanced wound management, nursing home and home healthcare, dermatology, wound and skin care for consumers, ani …
  • Aqua Bio Technology ASA (ABT):企業財務及び戦略的SWOT分析
    Summary Aqua Bio Technology ASA (ABT) is a biotechnology company that develops, produces and markets new active ingredients to the personal care industry. The company’s products include Aquabeautine XL and Smids. Its product Aquabeautine XL is derived from the hatching fluid of salmon. ABT’s product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆